Cargando…

Risks of Pneumonia in COPD Patients with New-Onset Atrial Fibrillation

The association between Atrial Fibrillation (AF) and pneumonia remains unclear. This study aims to assess the impact of AF on high pneumonia risk group—chronic obstructive pulmonary disease (COPD)—In order to find the association between AF and the risk of pneumonia. The COPD cohort was extracted fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ya-Hui, Lai, Chih-Cheng, Wang, Cheng-Yi, Wang, Hao-Chien, Yu, Chong-Jen, Chen, Likwang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162855/ https://www.ncbi.nlm.nih.gov/pubmed/30134632 http://dx.doi.org/10.3390/jcm7090229

Ejemplares similares

Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD
por: Lai, Chih-Cheng, et al.
Publicado: (2018)

The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) study
por: Wang, Cheng-Yi, et al.
Publicado: (2016)

Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist
por: Yang, Hsi-Hsing, et al.
Publicado: (2017)

Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD
por: Huang, Yueh Lan, et al.
Publicado: (2017)

The Impact of Sepsis on the Outcomes of COPD Patients: A Population-Based Cohort Study
por: Chen, Cheng-Hsin, et al.
Publicado: (2018)

Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists
por: Wang, Cheng-Yi, et al.
Publicado: (2019)

Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
por: Huang, Tsan-Ming, et al.
Publicado: (2020)

The association between COPD and outcomes of patients with advanced chronic kidney disease
por: Lai, Chih-Cheng, et al.
Publicado: (2018)

Risk of pneumonia in patients with gastroesophageal reflux disease: A population-based cohort study
por: Hsu, Wan-Tseng, et al.
Publicado: (2017)

Influence of Different Treatment Strategies on New‐Onset Atrial Fibrillation Among Patients With Primary Aldosteronism: A Nationwide Longitudinal Cohort‐Based Study
por: Pan, Chien‐Ting, et al.
Publicado: (2020)

New-Onset Atrial Fibrillation Is a Risk Factor of Ischemic Stroke in Chronic Obstructive Pulmonary Disease
por: Liu, Chi-Chun, et al.
Publicado: (2022)

Thromboembolic Risk in Patients With Pneumonia and New-Onset Atrial Fibrillation Not Receiving Anticoagulation Therapy
por: Søgaard, Mette, et al.
Publicado: (2022)

Statins reduce new-onset atrial fibrillation after acute myocardial infarction: A nationwide study
por: Tseng, Chien-Hao, et al.
Publicado: (2020)

New Onset Paroxysmal Atrial Fibrillation After Electroconvulsive Therapy
por: Hower, Michael R, et al.
Publicado: (2020)

Risk of Incident Non-Valvular Atrial Fibrillation after Dialysis-Requiring Acute Kidney Injury
por: Shiao, Chih-Chung, et al.
Publicado: (2018)

Comparison of New-Onset Diabetes Mellitus among Patients with Atrial Fibrillation or Atrial Flutter
por: Hu, Wei-Syun, et al.
Publicado: (2020)

New‐onset atrial fibrillation after atrial ischemia
por: Kondo, Yusuke, et al.
Publicado: (2019)

Risk of New-Onset Atrial Fibrillation Post-cavotricuspid Isthmus Ablation in Typical Atrial Flutter Without History of Atrial Fibrillation
por: Li, Jia-hui, et al.
Publicado: (2021)

New-Onset Atrial Fibrillation in the Critically Ill*
por: Moss, Travis J., et al.
Publicado: (2017)

Usefulness of HATCH score in the prediction of new-onset atrial fibrillation for Asians
por: Suenari, Kazuyoshi, et al.
Publicado: (2017)

New onset atrial fibrilation and risk faktors in COVID-19
por: Kelesoglu, Saban, et al.
Publicado: (2021)

Effect of drug-eluting stents on 1-year risk of new-onset atrial fibrillation in patients with acute myocardial infarction treated with percutaneous coronary intervention
por: Yu, Fa-Chang, et al.
Publicado: (2020)

Effects of cardiopulmonary bypass on new-onset atrial fibrillation
por: Gökalp, Orhan, et al.
Publicado: (2016)

Proteomics Profiling and Risk of New‐Onset Atrial Fibrillation: Framingham Heart Study
por: Ko, Darae, et al.
Publicado: (2019)

New-onset Atrial Fibrillation is Associated With Polycystic Kidney Disease: A Nationwide Population-based Cohort Study
por: Yu, Tung-Min, et al.
Publicado: (2016)

Prognostic impact of restored sinus rhythm in patients with sepsis and new-onset atrial fibrillation
por: Liu, Wen Cheng, et al.
Publicado: (2016)

Nutritional Status as a Risk Factor for New-Onset Atrial Fibrillation in Acute Myocardial Infarction
por: Wu, Liuyang, et al.
Publicado: (2023)

Prognostic indicators of new onset atrial fibrillation in patients with acute coronary syndrome
por: Zhang, Hengliang, et al.
Publicado: (2020)

Adiponectin and the risk of new-onset atrial fibrillation: a meta-analysis of prospective cohort studies
por: Guo, Ying, et al.
Publicado: (2019)

Taiwan Atrial Fibrillation Score: A New Clinical Tool for Predicting New Onset Atrial Fibrillation in Asian Populations
por: El Moheb, Mohamad, et al.
Publicado: (2021)

Associations of Abdominal Obesity and New‐Onset Atrial Fibrillation in the General Population
por: Baek, Yong‐Soo, et al.
Publicado: (2017)

High Burden of Premature Ventricular Complex Increases the Risk of New‐Onset Atrial Fibrillation
por: Lee, Po‐Tseng, et al.
Publicado: (2023)

Incidence and risk factors of atrial fibrillation in Asian COPD patients
por: Liao, Kuang-Ming, et al.
Publicado: (2017)

The Impact of 52-Week Single Inhaler Device Triple Therapy versus Dual Therapy on the Mortality of COPD Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Lai, Chih-Cheng, et al.
Publicado: (2022)

The Unexpected Pitter Patter: New-Onset Atrial Fibrillation in Pregnancy
por: White, Sarah, et al.
Publicado: (2015)

Liver Disease as a Predictor of New‐Onset Atrial Fibrillation
por: Huang, William A., et al.
Publicado: (2018)

Coronavirus Disease and New-Onset Atrial Fibrillation: Two Cases
por: Taha, Mohamed E, et al.
Publicado: (2020)

Predictors of new‐onset atrial fibrillation in geriatric trauma patients
por: Marco, Catherine A., et al.
Publicado: (2020)

PROGNOSTIC SIGNIFICANCE OF NEW-ONSET ATRIAL FIBRILLATION IN COVID-19
por: Ko, Darae, et al.
Publicado: (2022)

New-onset atrial fibrillation in intensive care: epidemiology and outcomes( )
por: Bedford, Jonathan P, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8ah0ce3d71mu7l2o3hq5t55l88